Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Martinelli, F."" wg kryterium: Autor


Tytuł :
Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer.
Autorzy :
Terada M; Medical Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.
Nakamura K; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.; Japan Clinical Oncology Group (JCOG), Data Center/Operations Office, Tokyo, Japan.
Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Mizusawa J; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.; Japan Clinical Oncology Group (JCOG), Data Center/Operations Office, Tokyo, Japan.
Eba J; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.; Japan Clinical Oncology Group (JCOG), Data Center/Operations Office, Tokyo, Japan.
Fukuda H; Clinical Research Support Office, National Cancer Center Hospital, Tokyo, Japan.; Japan Clinical Oncology Group (JCOG), Data Center/Operations Office, Tokyo, Japan.
Kiyota N; Department of Medical Oncology and Hematology, Kobe Univeersity Hospital Cancer Center, Kobe, Japan.
Gatellier L; Japan Brain Tumor Alliance, Yokohama, Japan.; Rare Cancers Japan, Tokyo, Japan.
Majima Y; PanCAN Japan, Tokyo, Japan.
Velikova G; Leeds Institute of Medical Research at St James's University of Leeds, Leeds, UK.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Oct 22; Vol. 50 (11), pp. 1333-1341.
Typ publikacji :
Journal Article
MeSH Terms :
Congresses as Topic*
Medical Oncology*
Quality of Life*
Neoplasms/*therapy
Endpoint Determination ; Europe ; Female ; Humans ; Japan ; Practice Patterns, Physicians' ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Autorzy :
Coens C; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Pe M; European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: .
Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
Sloan J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Calvert M; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research and National Institute for Health Research Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.
Campbell A; Patient Relevant Evidence, San Francisco, CA, USA.
Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cocks K; Adelphi Values, Bollington, Cheshire, UK.
Collette L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Devlin N; Centre for Health Policy, School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Dorme L; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
Gotay C; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Griebsch I; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
Groenvold M; Department of Public Health, Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
King M; School of Psychology, University of Sydney, Sydney, NSW, Australia.
Kluetz PG; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Malone DC; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Martinelli F; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Mitchell SA; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Musoro JZ; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
O'Connor D; Medicines and Healthcare products Regulatory Agency, London, UK.
Oliver K; International Brain Tumour Alliance, Surrey, UK.
Piault-Louis E; Genentech, Roche Group, San Francisco, CA, USA.
Piccart M; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
Reijneveld JC; Department of Neurology and Brain Tumor Center, VU University Medical Center, Amsterdam, Netherlands.
Schürmann C; Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Smith AW; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Soltys KM; Health Canada, Ottawa, ON, Canada.
Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden; Department of Neurology, Haaglanden Medical Center, The Hague, Netherlands.
Velikova G; Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK; International Society for Quality of Life Research, Milwaukee, WI, USA.
Bottomley A; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Pokaż więcej
Corporate Authors :
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data Consortium
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 Feb; Vol. 21 (2), pp. e83-e96.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Patient Reported Outcome Measures*
Quality of Life*
Neoplasms/*therapy
Randomized Controlled Trials as Topic/*standards
Research Design/*standards
Consensus ; Humans
Czasopismo naukowe
Tytuł :
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review.
Autorzy :
Mierzynska J; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Piccinin C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Pe M; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Gotay C; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Mauer M; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Eggermont A; Gustave Roussy Cancer Institute, Villejuif, France.
Groenvold M; Department of Public Health, University of Copenhagen, Copenhagen, Denmark; Department of Palliative Medicine, Bispebjerg Hospital, Copenhagen, Denmark.
Bjordal K; Department of Research Support Services, Oslo University Hospital, Oslo, Norway; Institute for Clinical Medicine, University of Oslo, Oslo, Norway.
Reijneveld J; Department of Neurology and Brain Tumour Center, Amsterdam University Medical Center, Amsterdam, Netherlands.
Velikova G; St James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, UK; Faculty of Medicine and Health, School of Medicine, University of Leeds, Leeds, UK.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Oncology [Lancet Oncol] 2019 Dec; Vol. 20 (12), pp. e685-e698.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Patient Reported Outcome Measures*
Quality of Life*
Neoplasms/*therapy
Humans ; International Agencies ; Patient Participation ; Prognosis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
Autorzy :
Coomans MB; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, Netherlands.
Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Baumert BG; Department of Radiation-Oncology, University Hospital Bonn, Bonn, Germany.; Department of Radiation Oncology (MAASTRO Clinic), and GROW (School for Oncology and Developmental Biology), Maastricht University Medical Center, Maastricht, Netherlands.
Van Den Bent M; the Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Brandes AA; Department of Medical Oncology, Local Health Unit Company-Institute of Hospitalization and Scientific Care (Azienda USL-IRCCS), Institute of Neurological Sciences, Bologna, Italy.
Chinot O; Aix-Marseille University, Neurophysiopathology Institute, University Hospital Center Timone, Neuro-Oncology Service, Marseille, France.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Gorlia T; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Herrlinger U; Division of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
Keime-Guibert F; Pitié-Salpetrière Hospital Group, Paris, France.
Malmström A; Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Stupp R; Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Talacchi A; Department of Neurosciences, San Giovanni Addolorata Hospital, Rome, Italy.
Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Wick W; Neurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany, and German Consortium of Translational Cancer Research, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Reijneveld JC; Department of Neurology and Brain Tumour Center Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands.
Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.; Department of Neurology, Haaglanden Medical Center, Den Haag, Netherlands.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2019 Nov 04; Vol. 21 (11), pp. 1447-1457.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Global Health*
Motor Activity*
Quality of Life*
Severity of Illness Index*
Fatigue/*etiology
Glioma/*complications
Pain/*etiology
Fatigue/psychology ; Female ; Health Status Indicators ; Humans ; Male ; Middle Aged ; Pain/psychology ; Palliative Care ; Randomized Controlled Trials as Topic ; Surveys and Questionnaires ; Symptom Assessment
Czasopismo naukowe
Tytuł :
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trials.
Autorzy :
Coomans M; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: .
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands; Department of Neurology, Haaglanden Medical Center, Den Haag, the Netherlands.
K Aaronson N; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Baumert BG; Department of Radiation-oncology, University Hospital Bonn, Germany; Department of Radiation Oncology (MAASTRO Clinic), and GROW (School for Oncology and Developmental Biology), Maastricht University Medical Center, Maastricht, the Netherlands.
van den Bent M; The Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Brandes AA; Department of Medical Oncology, Azienda USL-IRCCS Institute of Neurological Sciences, Bologna, Italy.
Chinot O; Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service de Neuro-Oncologie, Marseille, France.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Gorlia T; European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Herrlinger U; Division of Clinical Neurooncology, Department of Neurology and Center of Integrated Oncology (CIO), University of Bonn, Bonn, Germany.
Keime-Guibert F; Groupe Hôpital Pitié-Salpetrière, Paris, France.
Malmström A; Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Stupp R; Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Talacchi A; Department of Neurosciences, Azienda Ospedaliera San Giovanni Addolorata, Roma, Italy.
Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Wick W; Neurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany; German Consortium of Translational Cancer Research (DKTK), Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Reijneveld JC; Department of Neurology and Brain Tumour Center Amsterdam, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands; Department of Neurology, Haaglanden Medical Center, Den Haag, the Netherlands.
Pokaż więcej
Corporate Authors :
EORTC Quality of Life Group and the EORTC Brain Tumor Group
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Jul; Vol. 116, pp. 190-198. Date of Electronic Publication: 2019 Jun 13.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Brain Neoplasms/*complications
Brain Neoplasms/*mortality
Glioma/*complications
Glioma/*mortality
Brain Neoplasms/psychology ; Glioma/psychology ; Health Status ; Humans ; Prognosis ; Progression-Free Survival ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Autorzy :
Bottomley A; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Pe M; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Sloan J; 2 Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Basch E; 3 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Bonnetain F; 4 Methodology and Quality of Life Unit in Cancer, INSERM U1098, University Hospital of Besançon, Besançon, France.
Calvert M; 5 Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Campbell A; 6 Genentech, San Francisco, CA, USA.
Cleeland C; 7 Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cocks K; 8 Adelphi Values, Bollington, UK.
Collette L; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Dueck AC; 9 Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
Devlin N; 10 Office of Health Economics, London, UK.
Flechtner HH; 11 Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
Gotay C; 12 School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Greimel E; 13 Department of Obstetrics and Gynecology, Medical University Graz, Graz, Austria.
Griebsch I; 14 Boehringer Ingelheim, Frankfurt, Germany.
Groenvold M; 15 Department of Public Health, University of Copenhagen and Bispebjerg Hospital, Copenhagen, Denmark.
Hamel JF; 16 Methodology and Biostatistics Department, University Hospital of Angers UNAM, Angers, France.
King M; 17 School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Kluetz PG; 18 US Food and Drug Administration, Silver Spring, MD, USA.
Koller M; 19 Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Malone DC; 20 College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Martinelli F; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Mitchell SA; 21 Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Moinpour CM; 22 Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Musoro JZ; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
O'Connor D; 23 Medicines and Healthcare Products Regulatory Agency, London, UK.
Oliver K; 24 International Brain Tumour Alliance, Surrey, UK.
Piault-Louis E; 6 Genentech, San Francisco, CA, USA.
Piccart M; 25 Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium.
Pimentel FL; 26 Blueclinical Phase I, Porto, Portugal.; 27 Centro de Estudos e Investigação em Saúde da Universidade de Coimbra, Coimbra, Portugal.
Quinten C; 28 European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
Reijneveld JC; 29 VU University Medical Center, Department of Neurology & Brain Tumor Center, Amsterdam, The Netherlands.
Schürmann C; 30 Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Smith AW; 21 Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Soltys KM; 31 Health Canada, Ottawa, ON, Canada.
Sridhara R; 18 US Food and Drug Administration, Silver Spring, MD, USA.
Taphoorn MJB; 32 Leiden University Medical Center/Haaglanden Medical Center, Leiden/The Hague, The Netherlands.
Velikova G; 33 Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK.
Coens C; 1 Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Pokaż więcej
Źródło :
Clinical trials (London, England) [Clin Trials] 2018 Dec; Vol. 15 (6), pp. 624-630. Date of Electronic Publication: 2018 Aug 24.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Patient Reported Outcome Measures*
Quality of Life*
Randomized Controlled Trials as Topic*
Consensus Development Conferences as Topic ; Humans ; Neoplasms/therapy ; Practice Guidelines as Topic ; Research Design/standards
Czasopismo naukowe
Tytuł :
A systematic review examining factors influencing health related quality of life among melanoma cancer survivors.
Autorzy :
Hamel JF; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium; Biostatistics and Methodology Department, Angers University Hospital, Angers, France. Electronic address: .
Pe M; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Coens C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Martinelli F; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Eggermont AM; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
Brandberg Y; Oncology and Pathology Department, Karolinska Institutet, Stockholm, Sweden.
Bottomley A; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Dec; Vol. 69, pp. 189-198. Date of Electronic Publication: 2016 Nov 11.
Typ publikacji :
Journal Article; Review; Systematic Review
MeSH Terms :
Health Status*
Dermatologic Surgical Procedures/*methods
Melanoma/*psychology
Quality of Life/*psychology
Skin Neoplasms/*psychology
Survivors/*psychology
Age Factors ; Body Image/psychology ; Comorbidity ; Female ; Humans ; Interpersonal Relations ; Male ; Marital Status ; Melanoma/surgery ; Severity of Illness Index ; Sex Factors ; Skin Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Autorzy :
Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium. Electronic address: .
Pe M; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
Sloan J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
Bonnetain F; Methodology and Quality of Life Unit in Cancer, INSERM U1098, Universitary Hospital of Besançon, Besançon, France.
Calvert M; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, UK.
Campbell A; Genentech, a member of the Roche group, San Francisco, CA, USA.
Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cocks K; Adelphi Values, Bollington, Cheshire, UK.
Collette L; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
Devlin N; Office of Health Economics, London, UK.
Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
Gotay C; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Greimel E; Obstetrics and Gynecology, Medical University Graz, Graz, Austria.
Griebsch I; Boehringer-Ingelheim, Frankfurt, Germany.
Groenvold M; Department of Public Health and Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Hamel JF; Methodology and Biostatistics department, University Hospital of Angers UNAM, Angers, France.
King M; School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
Kluetz PG; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MA, USA.
Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
Malone DC; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
Martinelli F; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
Mitchell SA; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Moinpour CM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Musoro J; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
O'Connor D; Medicines and Healthcare products Regulatory Agency, London, UK.
Oliver K; International Brain Tumour Alliance, Surrey, UK.
Piault-Louis E; Genentech, a member of the Roche group, San Francisco, CA, USA.
Piccart M; Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium.
Pimentel FL; Health Sciences, University of Aveiro, Aveiro, Portugal; Lenitudes Medical Center & Research, Santa Maria da Feira, Portugal.
Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
Reijneveld JC; VU University Medical Center, Department of Neurology & Brain Tumor Center, Amsterdam, The Netherlands.
Schürmann C; Institute for Quality and Efficiency in Health Care, Cologne, Germany.
Smith AW; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Soltys KM; Health Canada, Ottawa, ON, Canada.
Taphoorn MJB; Leiden University Medical Center/Medical Center Haaglanden, Leiden/The Hague, Netherlands.
Velikova G; Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK.
Coens C; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
Pokaż więcej
Corporate Authors :
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints Data (SISAQOL) consortium
Źródło :
The Lancet. Oncology [Lancet Oncol] 2016 Nov; Vol. 17 (11), pp. e510-e514. Date of Electronic Publication: 2016 Oct 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clinical Trials as Topic*
Patient Reported Outcome Measures*
Quality of Life*
Neoplasms/*therapy
Humans ; Neoplasms/psychology
Czasopismo naukowe
Tytuł :
The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.
Autorzy :
Zikos E; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS) .
Coens C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Quinten C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ediebah DE; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Martinelli F; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ghislain I; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
King MT; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Gotay C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Ringash J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Velikova G; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Reeve BB; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Greimel E; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Cleeland CS; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Flechtner H; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Taphoorn MJ; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Weis J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Schmucker-von Koch J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Sprangers MA; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Bottomley A; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium (EZ, CC, DEE, FM, IG, AB); European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Stockholm, Sweden (CQ); School of Psychology and Sydney Medical School, University of Sydney, New South Wales, Australia (MTK); School of Population and Public Health, University of British Columbia, Vancouver, Canada (CG); The Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (JR); Leeds Institute of Cancer and Pathology, University of Leeds, St. James's Hospital, Leeds, UK (GV); Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC (BBR); Obstetrics and Gynecology, Medical University Graz, Graz, Austria (EG); Department of Symptom Research, Division of Internal Medicine, The University of Texas Anderson Cancer Center, Houston, TX (CSC); Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany (HF); VU University Medical Center / Medical Center Haaglanden, Amsterdam/The Hague, the Netherlands (MJBT); Tumor Biology Center, University of Freiburg, Freiburg, Germany (JW); Philosophical Faculty, University of Regensburg, Regensburg, Germany (JSvK); The Academic Medical Center, Amsterdam, the Netherlands (MAGS).
Pokaż więcej
Corporate Authors :
EORTC PROBE
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Dec 28; Vol. 108 (5). Date of Electronic Publication: 2015 Dec 28 (Print Publication: 2016).
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Health Status*
Quality of Life*
Neoplasms/*psychology
Neoplasms/*therapy
Constipation/etiology ; Europe ; Fatigue/etiology ; Humans ; Nausea/etiology ; Patient Satisfaction ; Prognosis ; Randomized Controlled Trials as Topic ; Research Design ; Self Report ; Survival Analysis ; Treatment Outcome ; Vomiting/etiology
Czasopismo naukowe
Tytuł :
The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 involving 6024 cancer patients.
Autorzy :
Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support, Epidemiological Methods Unit, Tomtebodavagen 11A, 171 83 Stockholm, Sweden. Electronic address: .
Coens C; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Ghislain I; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Zikos E; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Sprangers MA; Academic Medical Centre, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: .
Ringash J; The Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada. Electronic address: .
Martinelli F; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: francesca.martinelli@eortc.be.
Ediebah DE; Clinical Research, Abbott Vascular International BVBA, Park Lane, Culliganlaan 2B, 1831 Diegem, Belgium. Electronic address: .
Maringwa J; Quantative Solutions, Parkstraat 1b, 4818 SJ Breda, The Netherlands. Electronic address: .
Reeve BB; Gillings School of Global Public Health, University of North Caroline at Chapel Hill, 1101-D Mc Gavran-Greenberg Building, 135 Dauer Drive, CB 7411, Chapel Hill, NC 27599-7411, United States. Electronic address: .
Greimel E; Medical University Graz, Auenbruggerplatz 14, AT 8036 Graz, Austria. Electronic address: .
King MT; Cancer Australia Chair in Cancer Quality of Life, School of Psychology and Sydney Medical School, University of Sydney, New South Wales 2006, Australia. Electronic address: .
Bjordal K; Research Support Services, Oslo University Hospital, Sogn Arena, Pb 4950 Nydalen, NO-0424 Oslo, Norway. Electronic address: .
Flechtner HH; Child and Adolescent Psychiatry and Psychotherapy, Leipzigerstrasse 44, University of Magdeburg, 39120 Magdeburg, Germany. Electronic address: .
Schmucker-Von Koch J; Medical Ethics, Philosophical Faculty, University of Regensburg, Universitaetstrasse 31, 93040 Regensburg, Germany. Electronic address: .
Taphoorn MJ; VU Medical Center, De Boelelaan 1118, 1081 HZ Amsterdam, The Netherlands; Medical Center Haaglanden, P.O. Box 432, Lijnbaan 2, NL 2501 CK The Hague, The Netherlands. Electronic address: .
Weis J; Tumor Biology Center University Hospital Freiburg, Breisacherstrasse 117, 79106 Freiburg, Germany. Electronic address: .
Wildiers H; Department of General Medical Oncology, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: .
Velikova G; Faculty of Medicine and Health, Leeds Institute of Cancer & Pathology, University of Leeds, Bexley Wing (Level 4), St James's Hospital, Beckett Street, Leeds LS9 7TH, UK. Electronic address: .
Bottomley A; Quality of Life Department, EORTC Headquarters, Avenue E. Mounier 83/11, 1200 Brussels, Belgium. Electronic address: .
Pokaż więcej
Corporate Authors :
PROBE
EORTC Clinical Groups
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Dec; Vol. 51 (18), pp. 2808-19. Date of Electronic Publication: 2015 Nov 19.
Typ publikacji :
Journal Article; Meta-Analysis; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Aging/*psychology
Neoplasms/*psychology
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Australia ; Europe ; Female ; Geriatric Assessment ; Humans ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Metastasis ; Neoplasms/diagnosis ; Neoplasms/therapy ; New Zealand ; North America ; Prognosis ; Randomized Controlled Trials as Topic ; Risk Factors ; South Africa ; Surveys and Questionnaires ; Time Factors ; Young Adult
Czasopismo naukowe
Tytuł :
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Autorzy :
Quinten C; Quality of Life Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Martinelli F
Coens C
Sprangers MA
Ringash J
Gotay C
Bjordal K
Greimel E
Reeve BB
Maringwa J
Ediebah DE
Zikos E
King MT
Osoba D
Taphoorn MJ
Flechtner H
Schmucker-Von Koch J
Weis J
Bottomley A
Pokaż więcej
Corporate Authors :
Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups
Źródło :
Cancer [Cancer] 2014 Jan 15; Vol. 120 (2), pp. 302-11. Date of Electronic Publication: 2013 Oct 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Neoplasms/*etiology
Neoplasms/*mortality
Aged ; Female ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Self-Assessment
Czasopismo naukowe
Tytuł :
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Autorzy :
Quinten C; Quality of Life Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium. />Maringwa J
Gotay CC
Martinelli F
Coens C
Reeve BB
Flechtner H
Greimel E
King M
Osoba D
Cleeland C
Ringash J
Schmucker-Von Koch J
Taphoorn MJ
Weis J
Bottomley A
Pokaż więcej
Źródło :
Journal of the National Cancer Institute [J Natl Cancer Inst] 2011 Dec 21; Vol. 103 (24), pp. 1851-8. Date of Electronic Publication: 2011 Dec 07.
Typ publikacji :
Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Self Report*
Neoplasms/*complications
Neoplasms/*mortality
Adult ; Aged ; Clinical Trials as Topic ; Confounding Factors, Epidemiologic ; Constipation/etiology ; Diarrhea/etiology ; Europe/epidemiology ; Fatigue/etiology ; Female ; Humans ; Male ; Middle Aged ; Nausea/etiology ; Neoplasms/therapy ; Pain/etiology ; Predictive Value of Tests ; Proportional Hazards Models ; Randomized Controlled Trials as Topic ; Severity of Illness Index ; Surveys and Questionnaires ; Survival ; Survival Analysis ; Terminology as Topic ; United States/epidemiology ; Vomiting/etiology
Czasopismo naukowe
Tytuł :
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Autorzy :
Maringwa JT; Quality of Life Department, EORTC, Brussels, Belgium. />Quinten C
King M
Ringash J
Osoba D
Coens C
Martinelli F
Vercauteren J
Cleeland CS
Flechtner H
Gotay C
Greimel E
Taphoorn MJ
Reeve BB
Koch JS
Weis J
Smit EF
van Meerbeeck JP
Bottomley A
Pokaż więcej
Corporate Authors :
EORTC PROBE project and the Lung Cancer Group
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2011 Nov; Vol. 19 (11), pp. 1753-60. Date of Electronic Publication: 2010 Oct 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Quality of Life*
Surveys and Questionnaires*
Carcinoma, Non-Small-Cell Lung/*psychology
Lung Neoplasms/*psychology
Aged ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/therapy ; Female ; Humans ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Randomized Controlled Trials as Topic/methods ; Retrospective Studies ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Autorzy :
Martinelli F; Quality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium. francesca.martinelli@eortc.be
Quinten C
Maringwa JT
Coens C
Vercauteren J
Cleeland CS
Flechtner H
Gotay C
Greimel E
King M
Mendoza T
Osoba D
Reeve BB
Ringash J
Koch JS
Shi Q
Taphoorn MJ
Weis J
Bottomley A
Pokaż więcej
Corporate Authors :
European Organisation for Research and Treatment of Cancer Clinical Groups
Źródło :
Expert review of pharmacoeconomics & outcomes research [Expert Rev Pharmacoecon Outcomes Res] 2011 Oct; Vol. 11 (5), pp. 587-99.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Clinical Trials as Topic*
Quality of Life*
Neoplasms/*psychology
Adult ; Aged ; Female ; Health Status ; Humans ; Male ; Middle Aged ; Surveys and Questionnaires
Czasopismo naukowe
Tytuł :
Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients.
Autorzy :
Maringwa, J.
Quinten, C.
King, M.
Ringash, J.
Osoba, D.
Coens, C.
Martinelli, F.
Reeve, B. B.
Gotay, C.
Greimel, E.
Flechtner, H.
Cleeland, C. S.
Schmucker-Von Koch, J.
Weis, J.
Van Den Bent, M. J.
Stupp, R.
Taphoorn, M. J.
Bottomley, A.
Pokaż więcej
Źródło :
Annals of Oncology. Sep2011, Vol. 22 Issue 9, p2107-2112. 6p. 5 Charts.
Czasopismo naukowe
Tytuł :
Quality of life and sexual, bladder, and intestinal dysfunctions after class III nerve-sparing and class II radical hysterectomies: a questionnaire-based study.
Autorzy :
Ditto A; Department of Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. .
Martinelli F
Borreani C
Kusamura S
Hanozet F
Brunelli C
Rossi G
Solima E
Fontanelli R
Zanaboni F
Grijuela B
Raspagliesi F
Pokaż więcej
Źródło :
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2009 Jul; Vol. 19 (5), pp. 953-7.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Postoperative Complications*
Quality of Life*
Hysterectomy/*methods
Intestinal Diseases/*etiology
Sexual Dysfunction, Physiological/*etiology
Urinary Bladder Diseases/*etiology
Uterine Cervical Neoplasms/*surgery
Cross-Sectional Studies ; Female ; Humans ; Intestinal Diseases/diagnosis ; Middle Aged ; Sexual Dysfunction, Physiological/diagnosis ; Surveys and Questionnaires ; Urinary Bladder Diseases/diagnosis ; Uterine Cervical Neoplasms/radiotherapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies